Free Access
Med Sci (Paris)
Volume 31, Number 4, Avril 2015
Page(s) 374 - 376
Section Nouvelles
Published online 08 May 2015
  1. Blencowe H, Cousens S, Chou D, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013 ; 10 : suppl 1 S2. [CrossRef] [PubMed] [Google Scholar]
  2. Bennett P., Edmonds DK. Preterm labour. Dewhurst’s textbook of obstetrics and gynaecology. UK : Wiley-Blackwell, 2012 : 338–355. [CrossRef] [Google Scholar]
  3. Olson DM, Christiaens I, Gracie S, et al. Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy. Expert Opin Emerg Drugs 2008 ; 13 : 695–707. [CrossRef] [PubMed] [Google Scholar]
  4. Gomez-Lopez N, Tanaka S, Zaeem Z, et al. Maternal circulating leukocytes display early chemotactic responsiveness during late gestation. BMC Pregnancy Childbirth 2013 ; 13 : suppl 1 S8. [CrossRef] [PubMed] [Google Scholar]
  5. Romero R, Espinoza J, Goncalves LF, et al. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006 ; 11 : 317–326. [CrossRef] [PubMed] [Google Scholar]
  6. Christiaens I, Zaragoza DB, Guilbert L, et al. Inflammatory processes in preterm and term parturition. J Reprod Immunol 2008 ; 79 : 50–57. [CrossRef] [PubMed] [Google Scholar]
  7. Keelan JA, Khan S, Yosaatmadja F, Mitchell MD. Prevention of inflammatory activation of human gestational membranes in an ex vivo model using a pharmacological NF-kappaB inhibitor. J Immunol 2009 ; 183 : 5270–5278. [CrossRef] [PubMed] [Google Scholar]
  8. Kenakin T, Christopoulos A. Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov 2013 ; 12 : 205–216. [CrossRef] [PubMed] [Google Scholar]
  9. Goupil E, Tassy D, Bourguet C, et al. A novel biased allosteric compound inhibitor of parturition selectively impedes the prostaglandin F2alpha-mediated Rho/ROCK signaling pathway. J Biol Chem 2010 ; 285 : 25624–25636. [CrossRef] [PubMed] [Google Scholar]
  10. Böttcher B, Laterza RM, Wildt L, et al. A first-in-human study of PDC31 (prostaglandin F2alpha receptor inhibitor) in primary dysmenorrhea. Hum Reprod 2014 ; 29 : 2465–2473. [CrossRef] [PubMed] [Google Scholar]
  11. Jarreau PH. La prématurité. Med Sci (Paris) 2013 ; 29 : 819–820. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Lopez E, Jarreau PH. Inflammation et dysplasie bronchopulmonaire. Med Sci (Paris) 2013 ; 29 : 823–825. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.